GTR 111503048
Tenders Are Invited For Pharmaceutical Products – Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Raltegravir 400 Mg (Atc Code According To Who: J05aj01)
ICB — International Competitive Bid
Closes Jun 30, 2028
Western Europe
Tender Information
GTR Reference
111503048
Tendering Authority
Subscribe to view
Tender No
238743-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Raltegravir 400 Mg (Atc Code According To Who: J05aj01)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
30-06-2028
Work Detail
Pharmaceutical Products – Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Raltegravir 400 Mg (Atc Code According To Who: J05aj01). See Short Description
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
6e587ad5-6fb6-41f0-85fc-e642f74f701f.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.